T1	Condition 39 42	CPM
E1	Condition:T1 Name:T56
T2	And 43 47	with
E2	And:T2 Arg:E1 Arg2:E3
T3	Observation 57 72	life expectancy
E3	Observation:T3 Name:T57 Eq-Comparison:E4
T4	Eq-Comparison 76 86	> 6 months
E4	Eq-Comparison:T4 Operator:T58 Value:T59 Temporal-Unit:T60
T5	Observation 93 125	ECOG Scale of Performance Status
E5	Observation:T5 Name:T61
T6	Eq-Comparison 131 144	scores 0 or 1
E6	Eq-Comparison:T6 Value:T94 Value2:T95
T8	Modifier 199 207	systemic
E8	Modifier:T8 Modifies:T63
T9	Procedure 208 220	chemotherapy
E9	Procedure:T9 Name:T63
T10	Modifier 241 261	Concomitant systemic
E10	Modifier:T10 Modifies:T64
T11	Procedure 262 274	chemotherapy
E11	Procedure:T11 Name:T64
T12	Drug 289 296	FOLFIRI
E12	Drug:T12 Name:T65
T13	Drug 298 304	FOLFOX
E13	Drug:T13 Name:T66
T14	Drug 306 317	Mitomycin C
E14	Drug:T14 Name:T67
T15	Or 318 319	&
E15	Or:T15 Arg:E14 Arg2:E16
T16	Drug 325 337	Fluorouracil
E16	Drug:T16 Name:T68
T17	Drug 339 351	Capecitabine
E17	Drug:T17 Name:T69
T18	Exception 353 362	excluding
E18	Exception:T18 From:E17 Except:E19
T19	Drug 363 370	Lonsurf
E19	Drug:T19 Name:T62
T20	Or 372 374	or
E20	Or:T20 Arg:E17 Arg2:E58
T21	Modifier 383 391	systemic
E21	Modifier:T21 Modifies:T70
T22	Procedure 392 404	chemotherapy
E22	Procedure:T22 Name:T70
T23	Negation 408 410	no
E23	Negation:T23 Negates:E59
T24	Observation 454 470	Neutrophil count
E24	Observation:T24 Name:T71 Eq-Comparison:E28
T25	Temporal-Connection 471 473	on
E25	Temporal-Connection:T25 Arg:E24
T26	Temporal-Connection 482 488	before
E26	Temporal-Connection:T26 Arg:E27
A1	Temporal-Connection-Type-Value E26 before
T27	Procedure 489 501	chemotherapy
E27	Procedure:T27 Name:T72
T28	Eq-Comparison 514 518	>1.5
E28	Eq-Comparison:T28 Operator:T73 Value:T74
T29	Age 544 547	Age
E29	Age:T29 Eq-Comparison:E30
T30	Eq-Comparison 548 551	<18
E30	Eq-Comparison:T30 Operator:T75 Value:T76
T32	Procedure 600 605	PIPAC
E32	Procedure:T32 Name:T101
T34	Or 658 660	or
E34	Or:T34 Arg:E33 Arg2:E35
T36	Negation 698 701	not
E36	Negation:T36 Negates:E38 Negates2:E41
T37	Assertion 702 709	fit for
E37	Assertion:T37 Asserted:E38 Asserted2:E41
A3	Assertion-Type-Value E37 hypothetical
T38	Procedure 710 729	general anaesthesia
E38	Procedure:T38 Name:T78
T39	Or 730 738	and / or
E39	Or:T39 Arg:E38 Arg2:E41
T41	Procedure 739 750	laparoscopy
E41	Procedure:T41 Name:T79
T42	Condition 767 788	evident gross ascites
E42	Condition:T42 Name:T80
T43	Condition 794 811	Bowel obstruction
E43	Condition:T43 Name:T81
T44	Drug 817 828	Bevacizumab
E44	Drug:T44 Name:T82
T45	Procedure 849 861	chemotherapy
E45	Procedure:T45 Name:T83
T47	Procedure 881 893	chemotherapy
E47	Procedure:T47 Name:T84
T48	Procedure 897 904	surgery
E48	Procedure:T48 Name:T85
T49	Eq-Comparison 953 961	Previous
E49	Eq-Comparison:T49 Temporal-Period:T86
T50	Condition 962 985	bone marrow suppression
E50	Condition:T50 Name:T87 Temporality:E49
T51	Procedure 993 1005	chemotherapy
E51	Procedure:T51 Name:T88
T52	Risk 1012 1016	risk
E52	Risk:T52 Risk-For:E55
T53	Temporal-Connection 1020 1024	post
E53	Temporal-Connection:T53 Arg:E55 Arg2:E54
A4	Temporal-Connection-Type-Value E53 after
T54	Procedure 1025 1034	operative
E54	Procedure:T54 Name:T89
T55	Condition 1035 1046	neutropenia
E55	Condition:T55 Name:T90
T56	Condition-Name 39 42	CPM
T57	Observation-Name 57 72	life expectancy
T58	Eq-Operator 76 77	>
A5	Eq-Operator-Value T58 GT
T59	Eq-Value 78 79	6
T60	Eq-Temporal-Unit 80 86	months
A6	Eq-Temporal-Unit-Value T60 month
T61	Observation-Name 93 125	ECOG Scale of Performance Status
A7	Observation-Type-Value T61 clinical-score
T63	Procedure-Name 208 220	chemotherapy
T64	Procedure-Name 262 274	chemotherapy
T65	Drug-Name 289 296	FOLFIRI
T66	Drug-Name 298 304	FOLFOX
T67	Drug-Name 306 317	Mitomycin C
T68	Drug-Name 325 337	Fluorouracil
T69	Drug-Name 339 351	Capecitabine
T70	Procedure-Name 392 404	chemotherapy
T71	Observation-Name 454 470	Neutrophil count
A8	Observation-Type-Value T71 lab
T72	Procedure-Name 489 501	chemotherapy
T73	Eq-Operator 514 515	>
A9	Eq-Operator-Value T73 GT
T74	Eq-Value 515 518	1.5
T75	Eq-Operator 548 549	<
A10	Eq-Operator-Value T75 LT
T76	Eq-Value 549 551	18
T77	Condition-Name 557 560	MDT
T78	Procedure-Name 710 729	general anaesthesia
T79	Procedure-Name 739 750	laparoscopy
T80	Condition-Name 767 788	evident gross ascites
T81	Condition-Name 794 811	Bowel obstruction
T82	Drug-Name 817 828	Bevacizumab
T83	Procedure-Name 849 861	chemotherapy
T84	Procedure-Name 881 893	chemotherapy
T85	Procedure-Name 897 904	surgery
T86	Eq-Temporal-Period 953 961	Previous
A11	Eq-Temporal-Period-Value T86 past
T87	Condition-Name 962 985	bone marrow suppression
T88	Procedure-Name 993 1005	chemotherapy
T89	Procedure-Name 1025 1034	operative
T90	Condition-Name 1035 1046	neutropenia
T91	Modifier 48 56	expected
E56	Modifier:T91 Modifies:T57
T92	Observation 127 129	PS
E57	Observation:T92 Name:T93 Eq-Comparison:E6
T93	Observation-Name 127 129	PS
R1	Abbrev-Of Arg1:E57 Arg2:E5	
T94	Eq-Value 138 139	0
T95	Eq-Value 143 144	1
T7	Assertion 174 187	to facilitate
E7	Assertion:T7 Asserted:E9
A12	Assertion-Type-Value E7 hypothetical
R2	Using Arg1:E11 Arg2:E12	
R3	Using Arg1:E11 Arg2:E13	
R4	Using Arg1:E11 Arg2:E14	
R5	Using Arg1:E11 Arg2:E16	
R6	Using Arg1:E11 Arg2:E17	
T62	Drug-Name 363 370	Lonsurf
T96	Negation 375 382	without
E58	Negation:T96 Negates:E22
T97	Modifier 411 419	systemic
E59	Modifier:T97 Modifies:T70
T98	Assertion 428 437	available
E60	Assertion:T98 Asserted:E59
A13	Assertion-Type-Value E60 hypothetical
A14	Temporal-Connection-Type-Value E25 during
T99	Or 474 476	or
E61	Or:T99 Arg:E25 Arg2:E26
T100	Condition 557 560	MDT
E62	Condition:T100 Name:T77
T101	Procedure-Name 600 605	PIPAC
T31	Assertion 587 595	suitable
E31	Assertion:T31 Asserted:E32
A15	Assertion-Type-Value E31 hypothetical
T102	Negation 583 586	not
E63	Negation:T102 Negates:E32
R7	Treatment-For Arg1:E32 Arg2:E62	
T33	Procedure 623 646	Preoperative Assessment
E33	Procedure:T33 Name:T103
T103	Procedure-Name 623 646	Preoperative Assessment
T35	Provider 672 684	Anaesthetist
E35	Provider:T35 Type:T104
T104	Provider-Type 672 684	Anaesthetist
T105	Modifier 661 671	Consultant
E64	Modifier:T105 Modifies:T104
R8	Found-By Arg1:E36 Arg2:E33	
R9	Found-By Arg1:E36 Arg2:E35	
T40	Modifier 840 848	systemic
E40	Modifier:T40 Modifies:T83
R10	Using Arg1:E45 Arg2:E44	
T46	Procedure 927 932	PIPAC
E46	Procedure:T46 Name:T106
T106	Procedure-Name 927 932	PIPAC
T107	Temporal-Connection 894 896	to
E65	Temporal-Connection:T107 Arg:E47 Arg2:E48
A2	Temporal-Connection-Type-Value E65 after
T108	Assertion 905 913	would be
E66	Assertion:T108 Asserted:E46
A16	Assertion-Type-Value E66 hypothetical
R11	Caused-By Arg1:E50 Arg2:E51	
R12	Caused-By Arg1:E55 Arg2:E50	
